We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$814M
1-Year Est. Return
40.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.12%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$527M
AUM Growth
+$11.9M
(+2.3%)
Cap. Flow
-$332K
Cap. Flow
% of AUM
-0.06%
Top 10 Holdings %
Top 10 Hldgs %
16.32%
Holding
323
New
42
Increased
101
Reduced
106
Closed
15
Top Buys
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.56M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$7.42M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$6.3M |
| 4 |
Capri Holdings
CPRI
|
+$5.91M |
| 5 |
Pultegroup
PHM
|
+$4.78M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
+$7.67M |
| 2 |
Northern Oil and Gas
NOG
|
+$6.3M |
| 3 |
RVBD
RIVERBED TECHNOLOGY, INC COM
RVBD
|
+$5.44M |
| 4 |
Expeditors International
EXPD
|
+$5.13M |
| 5 |
CRR
Carbo Ceramics Inc.
CRR
|
+$3.08M |
Sector Composition
| 1 | Technology | 22.14% |
| 2 | Industrials | 14.54% |
| 3 | Financials | 9.32% |
| 4 | Communication Services | 8.36% |
| 5 | Healthcare | 7.65% |
Similar funds
VFG
KCP
AR
CICI
TFM
UAG
PS
BC
Stanley-Laman Group's Q4 2014 Portfolio in Review
As of Q4 2014, Stanley-Laman Group held 323 positions worth $527M, up 2.3% from $515M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Stanley-Laman Group's Q4 2014 filing shows 42 new, 101 increased, 106 reduced and 15 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 42,573 shares worth $8.75M. The largest sale was United Therapeutics, an estimated $7.67M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.
- Stanley-Laman Group's largest Q4 2014 buy was State Street SPDR S&P 500 ETF Trust: 42,573 shares worth $8.75M.
- Stanley-Laman Group added most to Qualcomm in Q4 2014, an estimated $602K increase.
- Stanley-Laman Group's biggest Q4 2014 reduction was IPG Photonics, cutting an estimated $1.53M.
- Stanley-Laman Group fully exited United Therapeutics in Q4 2014, selling an estimated $7.67M.
- Stanley-Laman Group's ten largest holdings make up 16% of its $527M portfolio in Q4 2014.
- Stanley-Laman Group opened 42 new positions and closed 15 in Q4 2014.
- Stanley-Laman Group's portfolio value rose 2.3% quarter-over-quarter to $527M.
Based on Stanley-Laman Group's 13F filing for Q4 2014, filed 30 Jan 2015.